Pharmaceuticals, Biotechnology and Life Sciences
the digital coach from Nori Health is made available for free from their website (use access code UKFREE) with the support of the Primary Care Society for Gastroenterology and its Chair, Dr Kevin Barrett.
Dupixent in patients 12 years and older with eosinophilic esophagitis (EoE) trial met both of its co-primary endpoints.
AstraZeneca has concluded the first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses so far and will begin first deliveries in September 2020.
Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the treatment of patients with gastric cancer, including gastroesophageal junction cancer.
Indica Labs and Octo have announced online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.
Virpax Pharmaceuticals has successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA)…
As the corona virus pandemic makes the conduct of clinical studies very complex and leads to standstill in many places,…
Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx, said that the company will release topline data from the LUMINA-2 study of CCX140.
Covid-19 has caused great interruption to pharmaceutical trials, as most resources have shifted to finding a vaccine and many ongoing trials have been disrupted, according to a report by Wakefield Research, an independent provider of market research and market intelligence.
Leinco Technologies and Vanderbilt University Medical Center (VUMC) have agreed to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.